[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344926-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344926-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","alox15-exerts-tumor-suppressive-role-in-head-and-neck-squamous-cell-carcinoma-via-erk-pathway-research","ALOX15 exerts tumor-suppressive role in head and neck squamous cell carcinoma via ERK pathway - Research","","Arachidonate 15-Lipoxygenase (ALOX15) is studied for its role in tumor biology, focusing on expression patterns, clinical relevance, and molecular mechanisms across cancers. Multi-omics analyses across 33 cancer types evaluate tumor progression, diagnostic value, prognosis, immune infiltration, and potential links to chemotherapy and immunotherapy, integrating TCGA and GTEx with other public resources. ALOX15 is downregulated in several cancers including HNSC, and low expression is validated as protective. Results connect ALOX15 to ERK signaling and show ERK-dependent suppression of malignant behaviors in functional experiments, supporting ALOX15 as a potential biomarker.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/alox15-exerts-tumor-suppressive-role-in-head-and-neck-squamous-cell-carcinoma-via-erk-pathway-research/344926/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/alox15-exerts-tumor-suppressive-role-in-head-and-neck-squamous-cell-carcinoma-via-erk-pathway-research/344926.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary objective of this study on ALOX15?","Question",{"text":63,"@type":64},"To characterize ALOX15 expression across 33 cancer types and determine its clinical relevance and molecular mechanisms, including diagnostic and therapeutic implications.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is ALOX15 expression related to prognosis in different cancers?",{"text":68,"@type":64},"Its expression correlates with prognosis in both positive and negative directions depending on the cancer type.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence supports ALOX15’s role in head and neck squamous cell carcinoma (HNSC)?",{"text":72,"@type":64},"HNSC clinical samples and cell line experiments show that low ALOX15 expression is linked to clinicopathological parameters and that ALOX15 overexpression suppresses malignant behaviors, with Western blot confirming ERK-pathway involvement.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344926,1791334014,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Functional & Integrative Genomics (2026) 26:64 [https://doi.org/10.1007/s10142-026-01838-8](https://doi.org/10.1007/s10142-026-01838-8)  \nRESEARCH  \nALOX15 exerts tumor-suppressive role in head and neck squamous cell carcinoma via ERK pathway  \nAoran Liu1 · Xinyue Zhang2 · Ruipeng Li1 · Yuzhe Zhang1 · Ziyi Yang3 · Dan Zou4 · Xu Ji5 · Hong Li3  \nReceived: 7 December 2025 / Revised: 8 February 2026 / Accepted: 10 February 2026 © The Author(s) 2026  \nAbstract  \nArachidonate 15-Lipoxygenase (ALOX15) has been implicated in cellular homeostasis, yet its pan-cancer expression patterns, clinical relevance, and molecular mechanisms remain incompletely characterized. This study comprehensively analyzed ALOX15 expression across 33 cancer types using multi-omics data to evaluate its role in tumor progression, diagnostic potential, and therapeutic implications. We integrated resources from TCGA, GTEx, and other public databases to assess ALOX15 expression, mutational status, diagnostic value, prognostic significance, immune infiltration, and potential relevance to chemotherapy and immunotherapy. Results showed that ALOX15 was downregulated in multiple cancers, including head and neck squamous cell carcinoma (HNSC), but upregulated in others such as liver cancer. Its expression exhibited both positive and negative correlations with prognosis depending on cancer type. Immune infiltration analysis revealed significant associations between ALOX15 and levels of B cells, CD8⁺ T cells, dendritic cells, and M1 macrophages in most tumors. Pathway analysis indicated a close relationship between ALOX15 and the ERK signaling pathway. Experimental validation in HNSC clinical samples and cell lines demonstrated that low ALOX15 expression was correlated with clinicopathological parameters and identified as a protective factor. Functional assays showed that ALOX15 overexpression suppressed malignant behavior in cancer cells. Western blot analysis further confirmed that ALOX15 inhibits HNSC progression via the ERK pathway. In summary, ALOX15 may serve as a potential biomarker across multiple cancer types.  \nGraphical abstract  \nThis study conducted a comprehensive pan-cancer bioinformatic analysis of ALOX15 using databases including TCGA, GTEx, HPA, and cBioPortal, with experimental validation in head and neck squamous cell carcinoma (HNSC) at both tissue and cellular levels. Immunohistochemical staining confirmed the expression and prognostic value of ALOX15 . Functional in vitro assays demonstrated that ALOX15 suppresses malignant behaviors in cancer cells, potentially through the ERK signaling pathway. These findings suggest ALOX15 as a potential biomarker in HNSC.  \nKeywords ALOX15 · Pan-cancer · HNSC · Biomarker · Immune · Prognostic  \nAoran Liu, Xinyue Zhang, Ruipeng Li and Yuzhe Zhang contributed equally to this work.  \nExtended author information available on the last page of the article  \n1 3  \nIntroduction  \nPan-cancer analysis provides a powerful framework for integrating multi-omics data across cancer types, revealing functional heterogeneity of genes in different tumor contexts, elucidating microenvironmental regulation of gene function, and offering a theoretical basis for developing precision therapeutics (Liu et al. 2022; Xu et al. 2024; Zhu et al. 2024) . In this study, we conducted a pan-cancer analysis of ALOX15 to systematically decipher its global role in tumorigenesis and progression, establishing a translational foundation for subsequent mechanistic investigations across malignancies.  \nArachidonate 15-lipoxygenase (ALOX15), a key enzyme in the lipoxygenase family, catalyzes the peroxidation of lipids into bioactive signaling mediators. It converts arachidonic acid (AA), a major component of membrane phospholipids and precursor to eicosanoid metabolites (Markworth et al. 2018), into 15-(S)-hydroperoxyeicosatetraenoic acid (15-(S)-HPETE) and 15-hydroxyeicosatetraenoic acid (15-HETE), which are further metabolized into various biologic","cbCaipaX7CvO17v0","https://ap.wps.com/l/cbCaipaX7CvO17v0","pdf",7318062,24,"English","# Abstract\n## Pan-cancer analysis overview\n## Expression, clinical relevance, and prognosis\n## Immune infiltration associations\n## Pathway linkage to ERK\n## Experimental validation in HNSC\n## Key implications and biomarker potential","[{\"question\":\"What is the primary objective of this study on ALOX15?\",\"answer\":\"To characterize ALOX15 expression across 33 cancer types and determine its clinical relevance and molecular mechanisms, including diagnostic and therapeutic implications.\"},{\"question\":\"How is ALOX15 expression related to prognosis in different cancers?\",\"answer\":\"Its expression correlates with prognosis in both positive and negative directions depending on the cancer type.\"},{\"question\":\"What experimental evidence supports ALOX15’s role in head and neck squamous cell carcinoma (HNSC)?\",\"answer\":\"HNSC clinical samples and cell line experiments show that low ALOX15 expression is linked to clinicopathological parameters and that ALOX15 overexpression suppresses malignant behaviors, with Western blot confirming ERK-pathway involvement.\"}]","ALOX15 exerts tumor-suppressive role in head and neck squamous cell carcinoma via ERK pathway - Research | PDF",1790055804,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48530b72923b2d74f6452db9bd67e6dd.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4736b5fee2d7207baca756224e17794f.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29f11fe21e6b6c60d65b0ca789e00ad4.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1bbd761796ab56d5fd8997f1ac54ffe9.webp",980,1301]